New molecular studies have supplied lots of insights in to the processes that govern the event and progression of CLL, like lots of novel mutated genes clustered in several useful pathways. The CLL epigenome is reprogrammed throughout the modulation of regulatory regions that surface de novo. intolerance). Ibrutinib is the current gold common thera